We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+279.61%
AUM
$129M
AUM Growth
+$127M
Cap. Flow
+$7.06M
Cap. Flow %
5.49%
Top 10 Hldgs %
27.93%
Holding
140
New
8
Increased
55
Reduced
50
Closed
6

Top Buys

Rank Stock Value
1
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$2.69M
2
COP icon
ConocoPhillips
COP
+$798K
3
QCOM icon
Qualcomm
QCOM
+$385K
4
INTC icon
Intel
INTC
+$335K
5
C icon
Citigroup
C
+$259K

Sector Composition

Rank Sector Weight
1 Technology 12.06%
2 Healthcare 11.57%
3 Financials 8.62%
4 Industrials 8.49%
5 Energy 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
51
MetLife
MET
$62.3B
$817K 0.64%
19,528
-898
-4% -$38.7K
UNP icon
52
Union Pacific
UNP
$174B
$781K 0.61%
10,054
SCHM icon
53
Schwab US Mid-Cap ETF
SCHM
$15.1B
$780K 0.61%
67,581
-1,383
-2% -$15.6K
LH icon
54
Labcorp
LH
$25.9B
$760K 0.59%
8,924
-431
-5% -$36.3K
VWO icon
55
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$752K 0.58%
18,729
+700
+4% +$27.7K
STT icon
56
State Street
STT
$50.9B
$721K 0.56%
10,975
-100
-0.9% -$6.84K
KO icon
57
Coca-Cola
KO
$375B
$716K 0.56%
18,895
+1,600
+9% +$63.2K
TAP icon
58
Molson Coors Class B
TAP
$8.13B
$704K 0.55%
14,045
-300
-2% -$15.1K
XBI icon
59
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$704K 0.55%
16,350
+270
+2% +$10.9K
T icon
60
AT&T
T
$164B
$692K 0.54%
27,106
-777
-3% -$20.4K
DIS icon
61
Walt Disney
DIS
$181B
$682K 0.53%
10,581
-25
-0.2% -$1.6K
MMM icon
62
3M
MMM
$94.5B
$650K 0.51%
6,509
SPY icon
63
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$649K 0.5%
3,864
IBM icon
64
IBM
IBM
$223B
$643K 0.5%
3,632
-76
-2% -$13.8K
D icon
65
Dominion Energy
D
$59.4B
$635K 0.49%
10,171
RSP icon
66
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$632K 0.49%
9,688
+165
+2% +$10.6K
HAS icon
67
Hasbro
HAS
$13.1B
$610K 0.47%
12,931
-275
-2% -$12.8K
DHR icon
68
Danaher
DHR
$144B
$609K 0.47%
13,072
EBAY icon
69
eBay
EBAY
$49.8B
$603K 0.47%
25,673
+7,211
+39% +$162K
PFE icon
70
Pfizer
PFE
$152B
$571K 0.44%
20,951
+316
+2% +$8.6K
CMI icon
71
Cummins
CMI
$88.7B
$565K 0.44%
4,259
+344
+9% +$42.5K
PGF icon
72
Invesco Financial Preferred ETF
PGF
$673M
$555K 0.43%
32,407
-800
-2% -$13.9K
IVW icon
73
iShares S&P 500 Growth ETF
IVW
$77.6B
$537K 0.42%
24,056
-760
-3% -$16.8K
C icon
74
Citigroup
C
$227B
$532K 0.41%
10,970
+5,125
+88% +$259K
NOV icon
75
NOV
NOV
$7.02B
$528K 0.41%
7,499
+2,861
+62% +$191K

Similar funds

Newman Dignan & Sheerar Inc's Q3 2013 Portfolio in Review

As of Q3 2013, Newman Dignan & Sheerar Inc held 140 positions worth $129M, up 9,778% from $1.3M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Newman Dignan & Sheerar Inc deployed $7.06M of net new capital in Q3 2013, opening 8 new positions and adding to 55 existing holdings. Its largest new stake was State Street SPDR S&P Dividend ETF: 38,979 shares worth $2.69M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 68% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $330K trimmed.

  • Newman Dignan & Sheerar Inc's largest Q3 2013 buy was State Street SPDR S&P Dividend ETF: 38,979 shares worth $2.69M.
  • Newman Dignan & Sheerar Inc added most to Qualcomm in Q3 2013, an estimated $385K increase.
  • Newman Dignan & Sheerar Inc's biggest Q3 2013 reduction was Thermo Fisher Scientific, cutting an estimated $330K.
  • Newman Dignan & Sheerar Inc fully exited Carlisle Companies in Q3 2013, selling an estimated $249.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 28% of its $129M portfolio in Q3 2013.
  • Newman Dignan & Sheerar Inc opened 8 new positions and closed 6 in Q3 2013.
  • Newman Dignan & Sheerar Inc's portfolio value rose 9,778% quarter-over-quarter to $129M.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q3 2013, filed 24 Oct 2013.